KeyBanc raises Reliance Steel stock price target on defense wins

Jim Cramer prefers Nucor (NUE) over Reliance (RS) but acknowledges RS's strength. Both companies reported strong Q2 results: RS revenue up 26.5% YoY, EPS up 41.5%; NUE EPS up to $5.04. Both expect higher steel prices but lower raw materials margins. Hedge fund holdings increased for both.

RELIANCE, INC. (RS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Reliance, Inc. Reports Second Quarter 2026 Financial Results - Net sales of $4.63 billion, up 15% sequentially with record tons sold up 7.0% - EPS of $6.29; non-GAAP EPS of $6.27, up 42% year-over-year, exceeding expect

SFL Corporation ordered two 93,000 cbm ammonia carriers for $216 million, deliverable in 2028. The company also secured long-term charters with an oil major, adding $162 million to its backlog. CEO Ole B. Hjertaker highlighted the investment's accretive nature and the charterer's investment-grade status. The total fixed-rate charter backlog for 2026 exceeds $1.3 billion.

Chevron (CVX) announced senior leadership changes effective January 1, 2027. Mark Nelson will focus on strategy and business development, Eimear Bonner will lead Oil, Products & Gas, Jeff Gustavson will become CFO, and Brent Gros will head New Energies and AI strategy. CEO Mike Wirth praised the new leaders' expertise and commitment.

Ultragenyx Pharmaceutical (NASDAQ: RARE) agreed to sell a rare pediatric disease priority review voucher for $210M, nearly half its cash reserves. The deal, subject to regulatory approval, follows the FDA's August approval of its Genglycos gene therapy. Shares rose 2.97% on the news. Ultragenyx plans to use proceeds to advance rare disease therapies and support profitability. The price is within the range of recent voucher transactions, such as Rocket Pharmaceuticals' $180M deal.

Warren Buffett and Berkshire Hathaway each report owning 12.5% of Lennar Corporation's Class A shares, totaling 26,034,436 shares with shared voting and dispositive power. National Indemnity Company holds 10.3%, or 21,502,349 shares. Other Berkshire affiliates also report significant stakes.